three Companies Search $1.3M In Charges From Zynerba CBD Gel Settlement

Law360 (July 28, 2021, 6:10 p.m. EDT) – Pomerantz LLP, the law firm Rosen, and Bronstein Gewirtz & Grossman LLC want more than $ 1.3 million to secure a $ 4 million settlement on behalf of investors who claim that CBD drug maker Zynerba Pharmaceuticals Inc. failed to disclose unfavorable clinical trial results.

In documents filed Tuesday, lead plaintiffs Scott Whiteley and Harry Berger asked U.S. District Judge Nitza I. Quiñones Alejandro to approve her attorney’s request for a fee equal to one-third of the multi-million dollar settlement fund. They also asked the judge to approve reimbursement of about $ 37,000 in legal costs, and found that Pomerantz got about $ 31,500 of that …

Stay ahead of the curve

In the legal profession, information is the key to success. You need to know what is happening to customers, competitors, practice areas and industries. Law360 offers the intelligence you need to stay an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, type of lawsuit, etc.)
  • Access to attached documents such as Briefs, petitions, complaints, decisions, motions, etc.
  • Create custom notifications for specific article and case topics and much more!

TRY THE LAW360 FREE SEVEN DAYS